Zdrowie i gospodarka · 03/08/1994
Prospective Grant of Exclusive License: Recombinant Virus Expressing Human Carcinoembryonic Antigen and Methods of Use Thereof
The National Institutes of Health (NIH) is contemplating a royalty-bearing exclusive license for the use of recombinant viruses expressing human carcinoembryonic antigen to Therion Biologics Corporation, with a 60-day public comment period.